Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
STAT Research, Inc.
mi
from
Dayton, OH
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
STAT Research, Inc.
mi
from
Dayton, OH
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Arthritis & Rheumatology Center Of Oklahoma Pllc
mi
from
Oklahoma City, OK
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Arthritis & Rheumatology Center Of Oklahoma Pllc
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Lynn Health Science Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
OMRF
mi
from
Oklahoma City, OK
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
OMRF
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Medical University of South Carolina
mi
from
Charleston, SC
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
UTMB Pathology Clinical Services
mi
from
Galveston, TX
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
UTMB Pathology Clinical Services
mi
from
Galveston, TX
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Arthritis & Osteoporosis Clinic
mi
from
Waco, TX
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Arthritis & Osteoporosis Clinic
mi
from
Waco, TX
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Danville Orthopedic Clinic, Inc.
mi
from
Danville, VA
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Danville Orthopedic Clinic, Inc.
mi
from
Danville, VA
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
The Mayo Clinic
mi
from
Rochester, MN
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Clinical Research Center of Reading, LLC
mi
from
Wyomissing, PA
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Clinical Research Center of Reading, LLC
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
APRILLUS
mi
from
Ciudad Autonoma Buenos aires,
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
APRILLUS
mi
from
Ciudad Autonoma Buenos aires,
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Center for Rheumatology, Immunology and Arthritis
mi
from
Fort Lauderdale, FL
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Center for Rheumatology, Immunology and Arthritis
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  12/4/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
A Phase IIb, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multidose, 24-Week Study to Evaluate the Efficacy and Safety of Atacicept in Subjects With Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 12/4/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Anniston Medical Clinic, PC
mi
from
Anniston, AL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Anniston Medical Clinic, PC
mi
from
Anniston, AL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Pinnacle Research Group, LLC
mi
from
Anniston, AL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Pinnacle Research Group, LLC
mi
from
Anniston, AL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Achieve Clinical Research
mi
from
Birmingham, AL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Achieve Clinical Research
mi
from
Birmingham, AL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Med Investigations
mi
from
Fair Oaks, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Med Investigations
mi
from
Fair Oaks, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Premier Clinical Research, LLC
mi
from
Lakewood, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Premier Clinical Research, LLC
mi
from
Lakewood, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Novo Research, Inc.
mi
from
Long Beach, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Novo Research, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
St. Mary Medical Center
mi
from
Long Beach, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
St. Mary Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
UCLA Division of Rheumatology
mi
from
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
UCLA Division of Rheumatology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
UCLA Rheumatology Clinical Research Center
mi
from
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
UCLA Rheumatology Clinical Research Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Ronald Reagan UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Inland Rheumatology and Osteoporosis Medical Group
mi
from
Upland, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Inland Rheumatology and Osteoporosis Medical Group
mi
from
Upland, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Inland Rheumatology Clinical Trials, Inc.
mi
from
Upland, CA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Asthma, Allergy, Arthritis and Lung Center
mi
from
Daytona Beach, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Asthma, Allergy, Arthritis and Lung Center
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern Arthritis Center
mi
from
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern Arthritis Center
mi
from
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern Community Pharmacy
mi
from
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern Community Pharmacy
mi
from
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern Integrated Medical, PL d/b/a Florida Medical Research Institute
mi
from
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern Integrated Medical, PL d/b/a Florida Medical Research Institute
mi
from
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Southeastern lmaging & Diagnostics
mi
from
Gainesville, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Southeastern lmaging & Diagnostics
mi
from
Gainesville, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
New Horizon Research Center
mi
from
Miami, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
New Horizon Research Center
mi
from
Miami, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Arthritis Associates
mi
from
Orlando, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Arthritis Associates
mi
from
Orlando, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Millennium Research
mi
from
Ormond Beach, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Millennium Research
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
The Arthritis Center
mi
from
Palm Harbor, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
The Arthritis Center
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Advent Clinical Research Centers
mi
from
Pinellas Park, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Advent Clinical Research Centers
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Burnette & Silverfield MDs, PLC
mi
from
Tampa, FL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Burnette & Silverfield MDs, PLC
mi
from
Tampa, FL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Emory University
mi
from
Atlanta, GA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Grady Health Systems
mi
from
Atlanta, GA
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Grady Health Systems
mi
from
Atlanta, GA
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Idaho Arthritis Center
mi
from
Meridian, ID
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Idaho Arthritis Center
mi
from
Meridian, ID
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Beacon Medical Group Rheumatology
mi
from
Granger, IN
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Beacon Medical Group Rheumatology
mi
from
Granger, IN
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Indiana CTSI Clinical Research Center
mi
from
Indianapolis, IN
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Indiana CTSI Clinical Research Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Investigational Drug Services
mi
from
Indianapolis, IN
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Investigational Drug Services
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Johns Hopkins Outpatient Center
mi
from
Baltimore, MD
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Johns Hopkins Outpatient Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated:  12/18/2017
Johns Hopkins Outpatient Express Testing Center
mi
from
Baltimore, MD
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
A Double-blind, Randomized, Placebo-controlled, Multicenter Dose-ranging Study To Evaluate The Efficacy And Safety Of Pf-04236921 In Subjects With Systemic Lupus Erythematosus (Sle)
Status: Enrolling
Updated: 12/18/2017
Johns Hopkins Outpatient Express Testing Center
mi
from
Baltimore, MD
Click here to add this to my saved trials